Form 4: Levi Strauss & Co. Director Yael Garten Reports Acquisition of Class A Common Stock

Sentiment:

SEC Form 4 Filing


Director Yael Garten of Levi Strauss & Co. acquired 88 shares of Class A Common Stock through dividend equivalent rights.

Summary

  • Yael Garten, a director at Levi Strauss & Co., reported acquiring 88 shares of Class A Common Stock.
  • The acquisition occurred on November 14, 2024, and was a result of dividend equivalent rights.
  • The price per share for the acquisition was $0.00.
  • Following the transaction, Yael Garten beneficially owns 48,368 shares of Class A Common Stock.
  • Some of the dividend equivalent rights are fully vested, while others will vest on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant date.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, which is generally neutral to positive. The director's increased stake could be seen as a positive sign.

Positives

  • The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to a director's stock ownership and is not indicative of any broader industry trends.

Comparison to Industry Standards

  • Director share acquisitions are common across publicly traded companies, and this transaction is consistent with standard practices.
  • The use of dividend equivalent rights is a typical method for compensating directors and aligning their interests with shareholders.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

DateDescription
11/14/2024Date of the transaction where Yael Garten acquired 88 shares of Class A Common Stock.
11/18/2024Date the SEC Form 4 was signed by Priscilla Duncan-Tannous, Attorney-in-Fact.

Keywords

Levi Strauss & Co., Director, Yael Garten, Class A Common Stock, Dividend Equivalent Rights, Share Acquisition, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.